메뉴 건너뛰기




Volumn 14, Issue 5, 2010, Pages

Treatment of euvolemic hyponatremia in the intensive care unit by urea

Author keywords

[No Author keywords available]

Indexed keywords

UREA; SODIUM CHLORIDE;

EID: 77957774160     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9292     Document Type: Article
Times cited : (111)

References (45)
  • 1
    • 66449093193 scopus 로고    scopus 로고
    • Hyponatremia in the intensive care unit
    • 10.1016/j.semnephrol.2009.03.003, 19523573
    • Palmer BF. Hyponatremia in the intensive care unit. Semin Nephrol 2009, 29:257-270. 10.1016/j.semnephrol.2009.03.003, 19523573.
    • (2009) Semin Nephrol , vol.29 , pp. 257-270
    • Palmer, B.F.1
  • 3
    • 60549103075 scopus 로고    scopus 로고
    • The epidemiology of intensive care unit-acquired hyponatremia and hypernatremia in medical-surgical intensice care units
    • 10.1186/cc7162, 2646327, 19094227
    • Stelfox MT, Ahmed SB, Khandwala F, Zygun D, Shahpori R, Lauplan K. The epidemiology of intensive care unit-acquired hyponatremia and hypernatremia in medical-surgical intensice care units. Crit Care 2008, 12:R162. 10.1186/cc7162, 2646327, 19094227.
    • (2008) Crit Care , vol.12
    • Stelfox, M.T.1    Ahmed, S.B.2    Khandwala, F.3    Zygun, D.4    Shahpori, R.5    Lauplan, K.6
  • 4
    • 76149146021 scopus 로고    scopus 로고
    • Impact of hospital-associated hyponatremia on selected outcomes
    • 10.1001/archinternmed.2009.513, 20142578
    • Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 2010, 170:294-302. 10.1001/archinternmed.2009.513, 20142578.
    • (2010) Arch Intern Med , vol.170 , pp. 294-302
    • Wald, R.1    Jaber, B.L.2    Price, L.L.3    Upadhyay, A.4    Madias, N.E.5
  • 5
    • 65249118223 scopus 로고    scopus 로고
    • The vaptans ante portas: a status report
    • 10.1093/ndt/gfp034, 19218537
    • Gross P, Marczewski T, Herbrig K. The vaptans ante portas: a status report. Nephrol Dial Transplant 2009, 24:1371-1373. 10.1093/ndt/gfp034, 19218537.
    • (2009) Nephrol Dial Transplant , vol.24 , pp. 1371-1373
    • Gross, P.1    Marczewski, T.2    Herbrig, K.3
  • 6
    • 33846521902 scopus 로고    scopus 로고
    • Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists
    • 10.1038/ncpneph0401, 17251996
    • Chen S, Jalandhara N, Battle D. Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists. Nat Clin Pract Nephrol 2007, 3:82-95. 10.1038/ncpneph0401, 17251996.
    • (2007) Nat Clin Pract Nephrol , vol.3 , pp. 82-95
    • Chen, S.1    Jalandhara, N.2    Battle, D.3
  • 7
    • 33646499848 scopus 로고    scopus 로고
    • Vaptans and the treatment of water-retaining disorders
    • 10.1016/j.semnephrol.2006.02.003, 16713496
    • Quitbnat F, Gross P. Vaptans and the treatment of water-retaining disorders. Semin Nephrol 2006, 26:234-243. 10.1016/j.semnephrol.2006.02.003, 16713496.
    • (2006) Semin Nephrol , vol.26 , pp. 234-243
    • Quitbnat, F.1    Gross, P.2
  • 8
    • 33745093213 scopus 로고    scopus 로고
    • Vasopressin receptor antagonists
    • 10.1038/sj.ki.5000432, 16672911
    • Greenberg A, Verbalis JG. Vasopressin receptor antagonists. Kidney Int 2006, 69:2124-2130. 10.1038/sj.ki.5000432, 16672911.
    • (2006) Kidney Int , vol.69 , pp. 2124-2130
    • Greenberg, A.1    Verbalis, J.G.2
  • 9
    • 43049146180 scopus 로고    scopus 로고
    • Non-peptide arginine-vasopressin antagonists: the vaptans
    • 10.1016/S0140-6736(08)60695-9, 18468546
    • Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 2008, 371:1624-1632. 10.1016/S0140-6736(08)60695-9, 18468546.
    • (2008) Lancet , vol.371 , pp. 1624-1632
    • Decaux, G.1    Soupart, A.2    Vassart, G.3
  • 10
    • 33744963977 scopus 로고    scopus 로고
    • Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patiens with euvolemic or hypervolemic hyponatremia
    • 10.1210/jc.2005-2287, 16522696
    • Ghali JK, Koren MJ, Tayor JR, Brooks-Asplund E, Fan K, Long WA, Smith N. Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patiens with euvolemic or hypervolemic hyponatremia. J Clin Endocrinol Metab 2006, 91:2145-2152. 10.1210/jc.2005-2287, 16522696.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 2145-2152
    • Ghali, J.K.1    Koren, M.J.2    Tayor, J.R.3    Brooks-Asplund, E.4    Fan, K.5    Long, W.A.6    Smith, N.7
  • 11
    • 0035348291 scopus 로고    scopus 로고
    • Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide
    • 10.1016/S0002-9343(01)00678-7, 11343672
    • Decaux G. Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide. Am J Med 2001, 110:582-584. 10.1016/S0002-9343(01)00678-7, 11343672.
    • (2001) Am J Med , vol.110 , pp. 582-584
    • Decaux, G.1
  • 12
    • 34748924247 scopus 로고    scopus 로고
    • Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia
    • 10.1159/000106456, 17664863, Conivaptan Study Group
    • Zeltser D, Rosansky S, van Rensburg H, Verbalis JG, Smith N, . Conivaptan Study Group Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol 2007, 27:447-457. 10.1159/000106456, 17664863, Conivaptan Study Group.
    • (2007) Am J Nephrol , vol.27 , pp. 447-457
    • Zeltser, D.1    Rosansky, S.2    van Rensburg, H.3    Verbalis, J.G.4    Smith, N.5
  • 13
    • 45349106231 scopus 로고    scopus 로고
    • Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatremia: subgroup analysis of a randomized, controlled study
    • 10.1111/j.1365-2265.2007.03149.x, 18034777
    • Verbalis JG, Zeltser D, Smith N, Barve A, Andoh M. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatremia: subgroup analysis of a randomized, controlled study. Clin Endocrinol (Oxf) 2008, 69:159-168. 10.1111/j.1365-2265.2007.03149.x, 18034777.
    • (2008) Clin Endocrinol (Oxf) , vol.69 , pp. 159-168
    • Verbalis, J.G.1    Zeltser, D.2    Smith, N.3    Barve, A.4    Andoh, M.5
  • 14
    • 62249203665 scopus 로고    scopus 로고
    • Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia
    • 10.1097/MAJ.0b013e31817b8148, 19057376, Conivaptan Study Group
    • Ananne D, Decaux G, Smith N, . Conivaptan Study Group Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia. Am J Med Sci 2009, 337:28-36. 10.1097/MAJ.0b013e31817b8148, 19057376, Conivaptan Study Group.
    • (2009) Am J Med Sci , vol.337 , pp. 28-36
    • Ananne, D.1    Decaux, G.2    Smith, N.3
  • 15
    • 70349327412 scopus 로고    scopus 로고
    • Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit
    • 10.1007/s12028-008-9179-3, 2820273, 19123060
    • Murphy T, Dhar R, Diringer M. Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit. Neurocrit Care 2009, 11:14-19. 10.1007/s12028-008-9179-3, 2820273, 19123060.
    • (2009) Neurocrit Care , vol.11 , pp. 14-19
    • Murphy, T.1    Dhar, R.2    Diringer, M.3
  • 16
    • 77951692168 scopus 로고    scopus 로고
    • Intravenous conivaptan for the treatment of hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience
    • 10.1093/ndt/gfp731, 20064953
    • Velez JC, Dopson SJ, Sanders DS, Delay TA, Arthur JM. Intravenous conivaptan for the treatment of hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience. Nephrol Dial Transplant 2010, 25:1524-1531. 10.1093/ndt/gfp731, 20064953.
    • (2010) Nephrol Dial Transplant , vol.25 , pp. 1524-1531
    • Velez, J.C.1    Dopson, S.J.2    Sanders, D.S.3    Delay, T.A.4    Arthur, J.M.5
  • 17
    • 33751005260 scopus 로고    scopus 로고
    • Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia
    • 10.1056/NEJMoa065181, 17105757, Salt Investigators
    • Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C, . Salt Investigators Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006, 355:2099-2112. 10.1056/NEJMoa065181, 17105757, Salt Investigators.
    • (2006) N Engl J Med , vol.355 , pp. 2099-2112
    • Schrier, R.W.1    Gross, P.2    Gheorghiade, M.3    Berl, T.4    Verbalis, J.G.5    Czerwiec, F.S.6    Orlandi, C.7
  • 18
    • 0018827023 scopus 로고
    • Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea
    • 10.1016/0002-9343(80)90506-9, 7386514
    • Decaux G, Brimioulle S, Genette F, Mockel J. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med 1980, 69:99-106. 10.1016/0002-9343(80)90506-9, 7386514.
    • (1980) Am J Med , vol.69 , pp. 99-106
    • Decaux, G.1    Brimioulle, S.2    Genette, F.3    Mockel, J.4
  • 19
    • 0020042626 scopus 로고
    • Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy
    • 10.1001/jama.247.4.471, 7054549
    • Decaux G, Unger J, Brimioulle S, Mockel J. Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy. JAMA 1982, 247:471-474. 10.1001/jama.247.4.471, 7054549.
    • (1982) JAMA , vol.247 , pp. 471-474
    • Decaux, G.1    Unger, J.2    Brimioulle, S.3    Mockel, J.4
  • 20
    • 0019520295 scopus 로고
    • Urea for long-term treatment of the syndrome of inappropriate secretion of antidiuretic hormone
    • 10.1136/bmj.283.6299.1081, 6794768
    • Decaux G, Genette F. Urea for long-term treatment of the syndrome of inappropriate secretion of antidiuretic hormone. Br Med J (Clin Res Ed) 1981, 283:1081-1083. 10.1136/bmj.283.6299.1081, 6794768.
    • (1981) Br Med J (Clin Res Ed) , vol.283 , pp. 1081-1083
    • Decaux, G.1    Genette, F.2
  • 21
    • 0037492960 scopus 로고    scopus 로고
    • Treatment of symptomatic hyponatremia
    • 10.1097/00000441-200307000-00004, 12861122
    • Decaux G, Soupart A. Treatment of symptomatic hyponatremia. Am J Med Sci 2003, 326:25-30. 10.1097/00000441-200307000-00004, 12861122.
    • (2003) Am J Med Sci , vol.326 , pp. 25-30
    • Decaux, G.1    Soupart, A.2
  • 22
    • 0033768022 scopus 로고    scopus 로고
    • Hyponatremia in the intensive care: from diagnosis to treatment
    • Decaux G, Musch W, Soupart A. Hyponatremia in the intensive care: from diagnosis to treatment. Acta Clinica Belgica 2000, 55:68-78.
    • (2000) Acta Clinica Belgica , vol.55 , pp. 68-78
    • Decaux, G.1    Musch, W.2    Soupart, A.3
  • 24
    • 49249137752 scopus 로고    scopus 로고
    • Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics
    • 10.1210/jc.2008-0330, 18477658
    • Fenske W, Stork S, Koschker AC, Blechschmidt A, Lorenz D, Wortmann S, Allolio B. Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J Clin Endocrinol Metab 2008, 93:2991-2997. 10.1210/jc.2008-0330, 18477658.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 2991-2997
    • Fenske, W.1    Stork, S.2    Koschker, A.C.3    Blechschmidt, A.4    Lorenz, D.5    Wortmann, S.6    Allolio, B.7
  • 25
    • 8944252996 scopus 로고
    • Urea - new use of an old agent. Reduction of intracranial and intraocular pressure
    • Javid M. Urea - new use of an old agent. Reduction of intracranial and intraocular pressure. Surg Clin North Am 1958, 38:907-928.
    • (1958) Surg Clin North Am , vol.38 , pp. 907-928
    • Javid, M.1
  • 26
    • 76549163536 scopus 로고
    • Blood changes on intravenous administration of mannitol or urea for reduction of intracranial pressure in neurosurgical patients
    • Buckell M. Blood changes on intravenous administration of mannitol or urea for reduction of intracranial pressure in neurosurgical patients. Clin Sci 1964, 27:223-227.
    • (1964) Clin Sci , vol.27 , pp. 223-227
    • Buckell, M.1
  • 27
    • 0009566281 scopus 로고
    • Urea transport in the central nervous system
    • Kleeman CR, Daison H, Levin E. Urea transport in the central nervous system. Am J Physiol 1962, 203:739-747.
    • (1962) Am J Physiol , vol.203 , pp. 739-747
    • Kleeman, C.R.1    Daison, H.2    Levin, E.3
  • 28
    • 0020631460 scopus 로고
    • Cerebral ventricular volume during hyponatremia
    • 10.1136/jnnp.46.5.443, 1027395, 6101182
    • Decaux G, Szyper M, Grivegnée A. Cerebral ventricular volume during hyponatremia. J Neurol Neurosurg Psychiatry 1983, 46:443-445. 10.1136/jnnp.46.5.443, 1027395, 6101182.
    • (1983) J Neurol Neurosurg Psychiatry , vol.46 , pp. 443-445
    • Decaux, G.1    Szyper, M.2    Grivegnée, A.3
  • 29
    • 0033919512 scopus 로고    scopus 로고
    • Treatment of acute hyponatremia: ensuring the excretion of a predictable amount of electrolyte-free water
    • 10.1097/00003246-200006000-00037, 10890640
    • Porzio P, Halberthal M, Bohn D, Halperin ML. Treatment of acute hyponatremia: ensuring the excretion of a predictable amount of electrolyte-free water. Crit Care Med 2000, 28:1905-1910. 10.1097/00003246-200006000-00037, 10890640.
    • (2000) Crit Care Med , vol.28 , pp. 1905-1910
    • Porzio, P.1    Halberthal, M.2    Bohn, D.3    Halperin, M.L.4
  • 31
    • 0031736648 scopus 로고    scopus 로고
    • Treating the syndrome of inappropriate secretion of ADH with isotonic saline
    • Musch W, Decaux G. Treating the syndrome of inappropriate secretion of ADH with isotonic saline. QJM 1998, 91:749-753.
    • (1998) QJM , vol.91 , pp. 749-753
    • Musch, W.1    Decaux, G.2
  • 32
    • 28844455012 scopus 로고    scopus 로고
    • Treatment of the polydipsia-hyponatremia syndrome with urea
    • 10.4088/JCP.v66n1105, 16420073
    • Verhoeven A, Musch W, Decaux G. Treatment of the polydipsia-hyponatremia syndrome with urea. J Clin Psychiatry 2005, 66:1372-1375. 10.4088/JCP.v66n1105, 16420073.
    • (2005) J Clin Psychiatry , vol.66 , pp. 1372-1375
    • Verhoeven, A.1    Musch, W.2    Decaux, G.3
  • 33
    • 70349661390 scopus 로고    scopus 로고
    • Oral urea treatment for polydipsia-hyponatremia syndrome in patients with schizophrenia
    • 10.1097/JCP.0b013e3181b3b38c, 19745654
    • Kawai N, Ishikawa K, Nemoto K, Katano T, Takahashi S, Hori T, Asada T. Oral urea treatment for polydipsia-hyponatremia syndrome in patients with schizophrenia. J Clin Psychopharmacol 2009, 29:499-501. 10.1097/JCP.0b013e3181b3b38c, 19745654.
    • (2009) J Clin Psychopharmacol , vol.29 , pp. 499-501
    • Kawai, N.1    Ishikawa, K.2    Nemoto, K.3    Katano, T.4    Takahashi, S.5    Hori, T.6    Asada, T.7
  • 34
    • 35649016098 scopus 로고    scopus 로고
    • Hyponatremia treatment guidelines 2007: expert panel recommendations
    • 10.1016/j.amjmed.2007.09.001, 17981159
    • Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med 2007, 120:S1-S21. 10.1016/j.amjmed.2007.09.001, 17981159.
    • (2007) Am J Med , vol.120
    • Verbalis, J.G.1    Goldsmith, S.R.2    Greenberg, A.3    Schrier, R.W.4    Sterns, R.H.5
  • 35
    • 49149116406 scopus 로고    scopus 로고
    • Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone
    • 10.2215/CJN.04431007, 18434618
    • Decaux G, Musch W. Clinical laboratory evaluation of the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol 2008, 3:1175-1184. 10.2215/CJN.04431007, 18434618.
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 1175-1184
    • Decaux, G.1    Musch, W.2
  • 36
    • 0029091287 scopus 로고
    • Combined fractional excretion of sodium and urea better predicts response to saline in hyponatremia than do usual clinical and biochemical parameters
    • 10.1016/S0002-9343(99)80180-6, 7573088
    • Musch W, Thimpont J, Vandervelde D, Vanhaeverbeke I, Berghmans T, Decaux G. Combined fractional excretion of sodium and urea better predicts response to saline in hyponatremia than do usual clinical and biochemical parameters. Am J Med 1995, 99:348-355. 10.1016/S0002-9343(99)80180-6, 7573088.
    • (1995) Am J Med , vol.99 , pp. 348-355
    • Musch, W.1    Thimpont, J.2    Vandervelde, D.3    Vanhaeverbeke, I.4    Berghmans, T.5    Decaux, G.6
  • 37
    • 0025962802 scopus 로고
    • Limits of brain tolerance to daily increments in serum sodium in chronically hyponatremic rats treated by hypertonic saline or urea
    • Soupart A, Stenuit A, Perier O, Decaux G. Limits of brain tolerance to daily increments in serum sodium in chronically hyponatremic rats treated by hypertonic saline or urea. Clin Sci (Lond) 1991, 80:77-84.
    • (1991) Clin Sci (Lond) , vol.80 , pp. 77-84
    • Soupart, A.1    Stenuit, A.2    Perier, O.3    Decaux, G.4
  • 38
    • 0033962490 scopus 로고    scopus 로고
    • Azotemia (48 h) decreases the risk of brain damage in rats after correction of chronic hyponatremia
    • 10.1016/S0006-8993(99)02259-3, 10661508
    • Soupart A, Penninckx R, Stenuit A, Decaux G. Azotemia (48 h) decreases the risk of brain damage in rats after correction of chronic hyponatremia. Brain Res 2000, 852:167-172. 10.1016/S0006-8993(99)02259-3, 10661508.
    • (2000) Brain Res , vol.852 , pp. 167-172
    • Soupart, A.1    Penninckx, R.2    Stenuit, A.3    Decaux, G.4
  • 39
    • 0036014924 scopus 로고    scopus 로고
    • Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-Inositol) in azotemic rats after correction of chronic hyponatremia
    • 10.1097/01.ASN.0000017903.77985.CD, 12039971
    • Soupart A, Silver S, Schroeder B, Sterns R, Decaux G. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-Inositol) in azotemic rats after correction of chronic hyponatremia. J Am Soc Nephrol 2002, 13:1433-1441. 10.1097/01.ASN.0000017903.77985.CD, 12039971.
    • (2002) J Am Soc Nephrol , vol.13 , pp. 1433-1441
    • Soupart, A.1    Silver, S.2    Schroeder, B.3    Sterns, R.4    Decaux, G.5
  • 40
    • 34547830282 scopus 로고    scopus 로고
    • Treatment of hyponatremia by urea decreases risks of brain complications in rats, a brain osmolyte contents analyses
    • 10.1093/ndt/gfm138, 17395650
    • Soupart A, Schroeder B, Decaux G. Treatment of hyponatremia by urea decreases risks of brain complications in rats, a brain osmolyte contents analyses. Nephrol Dial Transplant 2007, 22:1856-1863. 10.1093/ndt/gfm138, 17395650.
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 1856-1863
    • Soupart, A.1    Schroeder, B.2    Decaux, G.3
  • 41
    • 0027976776 scopus 로고
    • Prevention of brain demyelination in rats after excessive correction of chronic hypontremia by serum sodium lowering
    • 10.1038/ki.1994.23, 8127009
    • Soupart A, Penninckx R, Crenier L, Stenuit A, Perier O, Decaux G. Prevention of brain demyelination in rats after excessive correction of chronic hypontremia by serum sodium lowering. Kidney Int 1994, 45:193-200. 10.1038/ki.1994.23, 8127009.
    • (1994) Kidney Int , vol.45 , pp. 193-200
    • Soupart, A.1    Penninckx, R.2    Crenier, L.3    Stenuit, A.4    Perier, O.5    Decaux, G.6
  • 42
    • 0029914566 scopus 로고    scopus 로고
    • Reinduction of hyponatremia improves survival in rats with myelinolysis related neurologic symptoms
    • 10.1097/00005072-199605000-00011, 8627349
    • Soupart A, Penninckx R, Stenuit A, Decaux G. Reinduction of hyponatremia improves survival in rats with myelinolysis related neurologic symptoms. J Neuropathol Exp Neurol 1996, 55:594-601. 10.1097/00005072-199605000-00011, 8627349.
    • (1996) J Neuropathol Exp Neurol , vol.55 , pp. 594-601
    • Soupart, A.1    Penninckx, R.2    Stenuit, A.3    Decaux, G.4
  • 43
    • 69549135242 scopus 로고    scopus 로고
    • Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats
    • 10.1038/ki.2009.254, 19606078
    • Gankam Kengne F, Soupart A, Pochet R, Brion JP, Decaux G. Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int 2009, 76:614-621. 10.1038/ki.2009.254, 19606078.
    • (2009) Kidney Int , vol.76 , pp. 614-621
    • Gankam Kengne, F.1    Soupart, A.2    Pochet, R.3    Brion, J.P.4    Decaux, G.5
  • 44
    • 42549144456 scopus 로고    scopus 로고
    • DDAVP is effective in preventing and reversing inadevertent overcorrection of hyponatremia
    • 10.2215/CJN.03190807, 2390955, 18235152
    • Perianayagam A, Sterns RH, Silver SM, Grieff M, Mao R, Hix J, Konides R. DDAVP is effective in preventing and reversing inadevertent overcorrection of hyponatremia. Clin J Am Soc Nephrol 2008, 3:331-336. 10.2215/CJN.03190807, 2390955, 18235152.
    • (2008) Clin J Am Soc Nephrol , vol.3 , pp. 331-336
    • Perianayagam, A.1    Sterns, R.H.2    Silver, S.M.3    Grieff, M.4    Mao, R.5    Hix, J.6    Konides, R.7
  • 45
    • 78651242972 scopus 로고    scopus 로고
    • Efficacy and tolerance of vaptans compared to urea for long-term treatment of patients with SIADH: a prospective study
    • (abstract)
    • Soupart A, Decaux G. Efficacy and tolerance of vaptans compared to urea for long-term treatment of patients with SIADH: a prospective study. Acta Clinica Belgica 2009, 64:563. (abstract).
    • (2009) Acta Clinica Belgica , vol.64 , pp. 563
    • Soupart, A.1    Decaux, G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.